These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1656920)

  • 1. Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus.
    Mengeling WL
    Arch Virol; 1991; 120(1-2):57-70. PubMed ID: 1656920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency of a thymidine kinase-negative pseudorabies vaccine virus detected by the polymerase chain reaction.
    Volz DM; Lager KM; Mengeling WL
    Arch Virol; 1992; 122(3-4):341-8. PubMed ID: 1309996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams.
    Mengeling WL
    Am J Vet Res; 1989 Oct; 50(10):1658-66. PubMed ID: 2552871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes in the humoral immune response of pigs to pseudorabies virus after vaccination, exposure to virulent virus, and reactivation of latent virus.
    Mengeling WL; Pirtle EC
    J Vet Diagn Invest; 1990 Jan; 2(1):35-43. PubMed ID: 1965299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anamnestic immune response of pigs to pseudorabies virus: latent virus reactivation versus direct oronasal and parenteral exposure to virus.
    Mengeling WL
    J Vet Diagn Invest; 1991 Apr; 3(2):133-6. PubMed ID: 1654132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
    Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
    Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus.
    Ferrari M; Gualandi GL; Corradi A; Monaci C; Romanelli MG; Losio MN; Cantoni AM; Pratelli A
    Comp Immunol Microbiol Infect Dis; 2000 Jan; 23(1):15-26. PubMed ID: 10660255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine.
    Swenson SL; McMillen J; Hill HT
    J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs.
    Lei JL; Xia SL; Wang Y; Du M; Xiang GT; Cong X; Luo Y; Li LF; Zhang L; Yu J; Hu Y; Qiu HJ; Sun Y
    Immunol Lett; 2016 Jun; 174():63-71. PubMed ID: 27113530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical gene expression profile of pseudorabies virus reactivation from latency in swine trigeminal ganglion.
    Wang HH; Liu J; Li LT; Chen HC; Zhang WP; Liu ZF
    J Neurovirol; 2020 Oct; 26(5):687-695. PubMed ID: 32671812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
    Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
    Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence and pathogenesis of non-virulent and virulent strains of pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus.
    Mulder WA; Priem J; Glazenburg KL; Wagenaar F; Gruys E; Gielkens AL; Pol JM; Kimman TG
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():117-24. PubMed ID: 8113720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes.
    Wu CY; Liao CM; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Jul; 229():58-64. PubMed ID: 27164258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
    Kit S; Kit M; Pirtle EC
    Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes.
    Ferrari M; Mettenleiter TC; Romanelli MG; Cabassi E; Corradi A; Dal Mas N; Silini R
    J Comp Pathol; 2000; 123(2-3):152-63. PubMed ID: 11032669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes.
    Zuckermann FA; Zsak L; Mettenleiter TC; Ben-Porat T
    J Virol; 1990 Feb; 64(2):802-12. PubMed ID: 2153244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
    Mengeling WL; Brockmeier SL; Lager KM
    Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.